琥珀酸二苄酯 | 103-43-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 琥珀酸二苄酯
• 中文别名: 丁二酸苄酯
• 英文名称: dibenzyl succinate
• 英文别名: Dibenzyl-succinat；Bernsteinsaeure-dibenzylester；dibenzyl butanedioate
• CAS: 103-43-5
• 化学式: C₁₈H₁₈O₄
• mdl: MFCD00022034
• 分子量: 298.339
• InChiKey: ODBOBZHTGBGYCK-UHFFFAOYSA-N

物化性质

• 熔点：
  42-43°C
• 沸点：
  245°C/15mm
• 密度：
  1.256
• 闪点：
  245°C/15mm
• LogP：
  3.700 (est)
• 稳定性/保质期：
  避免与强氧化剂接触。

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  22
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 安全说明：
  S22,S24/25
• RTECS号：
  TU5011500
• 海关编码：
  2917190090
• 储存条件：
  储存于阴凉、通风的库房。远离火种、热源，应与氧化剂分开存放，切忌混储。配备相应的消防器材。储区内应备有泄漏应急处理设备和合适的收容材料。

反应信息

• 作为反应物：
  描述：

  琥珀酸二苄酯 在 pancreas-lipase 作用下， 生成 琥珀酸苄酯
  参考文献：
  名称：

  Howard, Journal of the American Chemical Society, 1922, vol. 44, p. 1764

  摘要：

  DOI：
• 作为产物：
  描述：

  乙酸苄酯 在 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 为溶剂， 反应 3.5h， 以68%的产率得到琥珀酸二苄酯
  参考文献：
  名称：

  五价联苯-2,2'-亚苯基铋试剂氧化偶联羰基化合物

  摘要：

  p-Tolylbiphenyl-2,2'-ylenebismuth bis(trifluoromethanesulfonate) 与衍生自酮、羧酸酯和硫酯的烯醇锂反应，提供相应的氧化偶联...

  DOI：

  10.1246/cl.2007.718

文献信息

• SELF-ASSEMBLY OF THERAPEUTIC AGENT-PEPTIDE NANOSTRUCTURES
  申请人：Ohio State Innovation Foundation

  公开号：US20140155577A1

  公开（公告）日：2014-06-05

  Disclosed are conjugates of hydrophobic drugs linked to protected or unprotected amino acids or peptides. The disclosed conjugates are amphiphilic and can self assemble into nanotubes. Nanotubes comprising the conjugates are also described and can have high loading of the drug and protect it from degradation or elimination. The nanotubes are well suited to deliver hydrophobic and unstable drugs to individuals.

  揭示了与受保护或未受保护的氨基酸或肽连接的疏水药物的共轭物。所述的共轭物是两性的，可以自组装成纳米管。还描述了包含这些共轭物的纳米管，可以具有高药物载荷并保护药物免受降解或排泄。这些纳米管非常适合向个体输送疏水和不稳定的药物。
• Amide/Iminium Zwitterionic Catalysts for (Trans)esterification: Application in Biodiesel Synthesis
  作者：Ying-Pong Lam、Xinyan Wang、Fei Tan、Wing-Hin Ng、Ying-Lung Steve Tse、Ying-Yeung Yeung

  DOI：10.1021/acscatal.9b01959

  日期：2019.9.6

  organocatalysts based on an amide anion/iminium cation charge pair has been developed. The zwitterions are easily prepared by reacting aziridines with aminopyridines. They are catalytically applicable to transesterifications and dehydrative esterifications. Mechanistic studies reveal that the amide anion and iminium cation work synergistically in activating the reaction partners, with the iminium cationic

  已经开发了一类基于酰胺阴离子/亚胺阳离子电荷对的两性离子有机催化剂。两性离子易于通过使氮丙啶与氨基吡啶反应来制备。它们催化地适用于酯交换和脱水酯化。机理研究表明，酰胺阴离子和亚胺阳离子在活化反应伙伴方面具有协同作用，亚胺阳离子部分通过非经典氢键与羰基底物相互作用。该反应可在温和条件下用于大规模合成生物柴油。
• LIPOPHILIC ANTICANCER DRUG COMPOUNDS, COMPOSITIONS AND RELATED METHODS
  申请人：Zhang Yuehua

  公开号：US20070142331A1

  公开（公告）日：2007-06-21

  Lipophilic anticancer drug compounds, compositions that include the compounds, and methods for treating a cell proliferative disease using the compounds.

  亲脂性抗癌药物化合物，包括该化合物的组合物，以及使用该化合物治疗细胞增殖性疾病的方法。
• DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS
  申请人：Seredenin Sergey Borisovich

  公开号：US20110312895A1

  公开（公告）日：2011-12-22

  The invention relates to compounds having either agonist or antagonist activities for the neurotrophins NGF and BDNF and represented by monomeric or dimeric substituted dipeptides that are analogs of the exposed portions of loop 1 or loop 4 regions of these neurotrophins near or at a beta-turn of the respective loop. N-acylated substituents of these dipeptides are biostereoisomers of the amino acid residues preceding these dipeptide sequences in the neurotrophin primary structure. The dimeric structure is produced advantageously by using hexamethylenediamine to which dipeptides are attached via their carboxyl groups. The claimed compounds displayed neuroprotective and differentiation-inducing activities in cellular models and enhanced the amount of phosphorylated tyrosine kinase A and the heat shock proteins Hsp32 and Hsp70 in the concentration range of 10 −9 to 10 −5 M. They also displayed neuroprotective, anti-parkinsonian, anti-stroke, anti-ischemic, anti-depressant and anti-amnestic activities in animal models and were active in experimental models of Alzheimer's disease. These in vivo effects of the claimed compounds are displayed in the dose range of 0.01 to 10 mg/kg when administered intraperitoneally.

  该发明涉及具有神经营养因子NGF和BDNF的激动剂或拮抗剂活性的化合物，这些化合物由单体或二聚体取代二肽代表，这些二肽代表这些神经营养因子的环1或环4区域的暴露部分的类似物，靠近或在各自环的β-转弯处。这些二肽的N-酰化取代物是神经营养因子原始结构中这些二肽序列之前的氨基酸残基的生物立体异构体。通过使用己二胺，优点地产生二聚体结构，二肽通过它们的羧基团连接到己二胺上。所述化合物在细胞模型中显示出神经保护和诱导分化活性，并在浓度范围为10^(-9)到10^(-5)M时增加了磷酸化酪氨酸激酶A和热休克蛋白Hsp32和Hsp70的量。它们还在动物模型中显示出神经保护、抗帕金森病、抗中风、抗缺血、抗抑郁和抗遗忘活性，并在阿尔茨海默病的实验模型中活跃。所述化合物的这些体内效应在腹腔内给药时的剂量范围为0.01至10毫克/千克。
• ZWITTERIONIC CATALYSTS FOR (TRANS)ESTERIFICATION: APPLICATION IN FLUOROINDOLE-DERIVATIVES AND BIODIESEL SYNTHESIS
  申请人：The Chinese University of Hong Kong

  公开号：US20210023539A1

  公开（公告）日：2021-01-28

  An amide/iminium zwitterion catalyst has a catalyst pocket size that promotes transesterification and dehydrative esterification. The amide/iminium zwitterions are easily prepared by reacting aziridines with aminopyridines. The reaction can be applied a wide variety of esterification processes including the large-scale synthesis of biodiesel. The amide/iminium zwitterions allow the avoidance of strongly basic or acidic condition and avoidance of metal contamination in the products. Reactions are carried out at ambient or only modestly elevated temperatures. The amide/iminium zwitterion catalyst is easily recycled and reactions proceed in high to quantitative yields.

  一种酰胺/亚胺兹维特离子催化剂具有促进酯交换和脱水酯化的催化剂口袋尺寸。酰胺/亚胺兹维特离子通过将环氮烷与氨基吡啶反应而容易制备。该反应可应用于各种酯化过程，包括生物柴油的大规模合成。酰胺/亚胺兹维特离子可避免强碱性或酸性条件，并避免产品中的金属污染。反应在常温或仅略微升温下进行。酰胺/亚胺兹维特离子催化剂易于回收，反应产率高且接近定量。

表征谱图